Lack of effect of bone morphogenetic protein 2 and 4 gene polymorphisms on bone density in postmenopausal Turkish women

被引:8
作者
Ozkan, Z. S. [1 ]
Deveci, D. [2 ]
Etem, E. Onalan [2 ]
Yuce, H. [2 ]
机构
[1] Kecioren Educ & Res Hosp, Dept Gynecol, Ankara, Turkey
[2] Firat Univ, Dept Genet, TR-23169 Elazig, Turkey
来源
GENETICS AND MOLECULAR RESEARCH | 2010年 / 9卷 / 04期
关键词
Bone mineral density; Single-nucleotide polymorphism; Bone morphogenetic protein 2 and 4; Genetic association; Osteoporosis; MINERAL DENSITY; OSTEOPOROSIS; DETERMINANTS; MEN;
D O I
10.4238/vol9-4gmr922
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the effect of bone morphogenetic protein 2 and 4 (BMP-2 and -4) gene polymorphisms on bone density in postmenopausal Turkish women with osteoporosis. The frequency of single-nucleotide polymorphisms (SNPs) of BMP-2 and -4 genes was analyzed in 101 osteoporotic-postmenopausal women and 52 postmenopausal women with positive bone mineral density scores. We evaluated the frequency of the thymine -> cytosine nucleotide variation at position 538 for BMP-4 and the transposition of adenine -> thymine at codon 190 for BMP-2, with PCR. The proportions of genotypes observed for the BMP-2 SNP in the osteoporotic group were AA (47.5%), AT (39.6%), TT (12.9%), and in the non-osteoporotic group they were AA (48.1%), AT (40.4%), TT (11.5%). The corresponding frequencies for the BMP-4 SNP in the osteoporotic group were TT (30.7%), TC (45.5%), CC (23.8%), and in the non-osteoporotic group they were TT (26.9%), TC (40.4%), CC (32.7%). There were no significant differences in the frequencies of these genotypes between the patient and control groups. We conclude that genetic variations in BMP-2 and -4 do not substantially contribute to lumbar spine bone mineral density in postmenopausal Turkish women.
引用
收藏
页码:2311 / 2316
页数:6
相关论文
共 19 条
  • [1] Bone mass effects of a BMP4 gene polymorphism in postmenopausal women
    Babu, LR
    Wilson, SG
    Dick, IM
    Islam, FMA
    Devine, A
    Prince, RL
    [J]. BONE, 2005, 36 (03) : 555 - 561
  • [2] The diagnosis and treatment of osteoporosis: future prospects
    Baylink, DJ
    Strong, DD
    Mohan, S
    [J]. MOLECULAR MEDICINE TODAY, 1999, 5 (03): : 133 - 140
  • [3] Bone morphogenetic protein-2 activity is regulated by secreted phosphoprotein-24 kd, an extracellular pseudoreceptor, the gene for which maps to a region of the human genome important for bone quality
    Brochmann, Elsa J.
    Behnam, Keyvan
    Murray, Samuel S.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2009, 58 (05): : 644 - 650
  • [4] Single-nucleotide polymorphisms and haplotypes of bone morphogenetic protein genes and peripheral bone mineral density in young Korean men and women
    Choi, JY
    Shin, CS
    Hong, YC
    Kang, D
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2006, 78 (04) : 203 - 211
  • [5] Human genetics of osteoporosis
    Ferrari, Serge
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 22 (05) : 723 - 735
  • [6] FLICKER L, 1995, J BONE MINER RES, V10, P1607
  • [7] Polymorphisms in the bone morphogenetic protein 2 (BMP2) gene do not affect bone mineral density in white men or women
    Ichikawa, S
    Johnson, ML
    Koller, DL
    Lai, D
    Xuei, X
    Edenberg, HJ
    Hui, SL
    Foroud, TM
    Peacock, M
    Econs, MJ
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 (04) : 587 - 592
  • [8] Ireland P, 1994, Asia Pac J Clin Nutr, V3, P19
  • [9] A single-nucleotide polymorphism in the human bone morphogenetic protein-4 (BMP 4) gene
    Mangino, M
    Torrente, I
    De Luca, A
    Sanchez, O
    Dallapiccola, B
    Novelli, G
    [J]. JOURNAL OF HUMAN GENETICS, 1999, 44 (01) : 76 - 77
  • [10] BMP-2 gene polymorphisms and osteoporosis:: The Rotterdam Study
    Medici, Marco
    van Meurs, Joyce B. J.
    Rivadeneira, Fernando
    Zhao, HongYan
    Arp, Pascal P.
    Hofman, Albert
    Pols, Huibert A. P.
    Uitterlinden, Andre G.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (06) : 845 - 854